Thank you!
Your support is sustaining the future of local news in our communities.

Future of weight loss

More than 40% of Americans are now classified as obese while 75% of adults are either overweight or obese. A new group of drugs called GLP-1 receptor agonists have come on the scene to help in the battle to lose weight. Are they as good as we think?

You may have heard about them or some of their brand names like Zepbound, Wegovy, and Ozempic. The use of these drugs has exploded in popularity to the point where companies like Lilly and Novo Nordisk have had problems keeping up with demand. There is nothing magical about the science behind these drugs. GLP-1 mimics a protein naturally produced by our small intestines. The receptors for these medicines are located across the body. They help us lose weight because receptors in the gastrointestinal tract slow down and send signals to the brain that give us a sense of feeling full.

There are some side effects but nothing too serious for most patients. We are still learning how these medications impact the body. They are currently approved for treating diabetes, obesity, and those with a history of cardiovascular disease in people who are overweight. There are a few drawbacks to these drugs at present.

Typically, GLP-1 agonists are administered as injections in the abdomen, upper arms, outer thighs, or upper buttocks via a syringe and needle or a pre-filled dosing pen. The shots are generally taken once a day or once a week.

For many, this is a big turn-off. Fortunately, you will be able to take tablets soon. The typical weight loss is from 5-15% of body weight over at least 12 months. But GLP-1 is no quick fix. Like exercise, you must stick with it. If you stop taking it, most people regain the weight they lost. And you can’t expect to magically lose weight while you continue to eat all that junk food you get.

The second drawback is the expense. These medications’ list price is around $1,000 a month to $1,400 a month. Without insurance, we are talking $12,000 plus per year for these drugs. Many insurance plans cover some portion of GLP-1 costs, but the extent of coverage can vary significantly. You probably are wondering whether Medicare covers GLP-1 medications. They do for certain medically accepted indications such as heart attack or cardiovascular disease but not for weight management. To qualify, you must have a BMI of 30 or higher, or 27 or higher with comorbidities like high blood pressure, high cholesterol, or type 2 diabetes. They are currently covered through Part D plans.

An entirely new team of individuals, including a retired congressman, a surgeon, and a talk-show host could play pivotal roles in how the government goes about safeguarding America’s health.

Coinsurance amounts are pegged to the list price of drugs. As such, Medicare beneficiaries who qualify could still face monthly costs of $250 to $430 before they reach the annual out-of-pocket drug spending established by the Inflation Reduction Act (IRA). The IRA cap for out-of-pocket expenses were around $3,300 in 2024 and will be $2,000 in 2025. Most retirees living on modest incomes would still find the cost of GLP-1 prohibitive.

In November 2024, the Biden Administration proposed that Medicare and Medicaid cover obesity medications. In doing so, they sidestepped a twenty-year-old piece of legislation that prevented Medicare from covering drugs for ‘weight loss.’ The new proposal specifies that the drugs would be covered to treat the disease of obesity and prevent related conditions. Those conditions are serious and include diabetes, high blood pressure, cardiovascular disease, sleep apnea, fatty liver disease, and arthritis.

The classification would also mean that every state Medicaid program would be required to cover the drugs starting in 2026. Between the two programs, an additional 7.4 million Americans would gain coverage. The price tag would be high, at least $36 billion over a decade. However, there are more obesity drugs in the pipeline and prices should fall as competition heats up. Starting in 2025, Medicare will also be able to negotiate a lower price for Wegovy as well as many other popular drugs.

As for the future, the costs and usage of GLP-1 medications could change significantly under the second Trump Administration. An entirely new team of individuals, including a retired congressman, a surgeon, and a talk-show host could play pivotal roles in how the government goes about safeguarding America’s health.

Under Robert F. Kennedy, an environmental lawyer, politician, and anti-vaccine organizer, we can expect radically different views and actions in health care, medicine, food safety, and science research. Early indications are that Kennedy, who would run the Department of Health and Human Services, is not a big fan of Ozempic. He does not believe that using popular GLP-1 drugs is ever going to make America healthy again. His remedy would be to provide good food to Americans. He believes that providing three nutritious meals a day to all Americans would solve obesity and diabetes overnight. The problem is that for many Americans the admonition to change your diet, eat less, and exercise more has failed to dent the problem. Why not give the country an avenue that shows a much better chance of success over the long term?



Bill Schmick is a founding partner of Onota Partners, Inc., in the Berkshires.

The views expressed here are not necessarily those of The Lakeville Journal and The Journal does not support or oppose candidates for public office.

Latest News

Yerger Johnstone

Yerger Johnstone

SHARON — Yerger Johnstone, former managing director in the mergers and acquisitions department at Morgan Stanley and a decorated veteran of the Vietnam War, died on April 19, 2026, in Chelmsford, England. He was 86.

Born in Mobile, Alabama, on March 7, 1940, Mr. Johnstone was the son of architect Henry Inge Johnstone, architect, and Kathleen Yerger Johnstone, the noted nature writer and civic leader after whom Alabama’s state seashell, Johnstone’s Junonia, is named. He graduated from Murphy High School in Mobile in 1958, received his bachelor’s degree from the University of the South at Sewanee in 1962, and earned his M.B.A. from the University of Chicago Booth School of Business in 1964.

Keep ReadingShow less

Richard R. Stover

Richard R. Stover

WEST CORNWALL — Richard R. Stover, 82, of West Cornwall, died peacefully at Noble Horizons on May 26, 2026.

Son of the late Robert and Leona (Heinbockel) Stover, Rick was born Feb. 6, 1944 in Edina, Minnesota. He attended the University of Pennsylvania where he majored in Economics and was a member of Sigma Alpha Epsilon fraternity.

Keep ReadingShow less

Floyd Irving Isham

Floyd Irving Isham

SHARON — Floyd Irving Isham Jr., 87, a longtime area resident, died Tuesday, May 26, 2026, at Sharon Health Care Center in Sharon. Mr. Isham worked for the Tri-Wall Container Corp. in Wassaic, New York, for fifteen years and also worked as a self-employed private caretaker for over twenty-five years, caring for local estates in Shekomeko, Pine Plains and Ancramdale, New York, prior to his retirement.

Born Aug. 25, 1938, in St. George, Vermont, he was the son of the late Floyd Irving and Hazel (Thompson) Isham, Sr. Following his high school years, he enlisted in the United States Navy and served from 1958 until his honorable discharge in 1961. Mr. Isham also served in the Vermont National Guard. On Aug. 11, 1990, in Dover Plains, New York, he married Nancy L. Cross. Mrs. Isham died on July 8, 2005.

Keep ReadingShow less
google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.

Pauline King Garfield

Pauline King Garfield

EAST CANAAN — Pauline K. (King) Garfield, 94 of 77 South Canaan Rd. formerly of East Canaan, died Sunday May 24, 2026, at Geer Village. She was the wife of the late Duane Garfield who passed August 14, 2017. Pauline was born April 3, 1932 in North Canaan,in the former Geer Hospital. She was the daughter of the late Charles and Rose (Van Vlack) King.

Pauline spent her career at Becton Dickinson in Canaan, after being a stay-at-home mother for many years.She was employed at Becton Dickinson for 23 years. She enjoyed bus trips with her late husband Duane to the Casinos, spending time with her family watching the grandchildren grow up. Recently she made a comment to care givers that was “wait until I see that husband of mine for leaving me here, I am going to read him the riot act.” Over the years she enjoyed many crafts, but her favorite was crocheting gifts for everyone.

Keep ReadingShow less
Great Country Mutt Show returns as animal shelter surrenders rise

Great Dane “Axel” with owner Sage Breyette in the Best Lap Dog Over 40 lbs. contest at last year’s Great Country Mutt Show

Aly Morrissey

Tail wags, floppy ears and a healthy dose of canine charm will take center stage June 7 as The Little Guild hosts its annual Great Country Mutt Show at Lime Rock Park in Falls Village.

Last year’s Great Country Mutt Show attracted more than 200 dogs and 800 people. Founded by renowned designer Bunny Williams as a benefit for the Little Guild, the tongue-in-cheek, Westminster-style event has grown into one of the organization’s signature annual fundraisers and community celebrations. The show remains free and open to the public, and adoptable dogs may attend when appropriate.

Keep ReadingShow less

Savannah Stevenson’s second act

Savannah Stevenson’s second act

Savannah Stevenson as Mrs. Paroo and Elliott Andrews who plays Harold Hill in the nationally touring production of “The Music Man.”

Marshall Meadows
Sharing laughter, tears, music and dancing through stories that illuminate our common humanity touches us in a way that builds connection, empathy and genuine community.
— Savannah Stevenson

Savannah Stevenson has lived enough lives already to make most people feel lazy.

She grew up in Atlanta in a musical family, with a father who played “The Sound of Music” cassette tapes in the car and a mother who played hymns on the piano. She went to Carnegie Mellon to study musical theater, moved to New York afterward and, for a while, imagined a life onstage.

Keep ReadingShow less
google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.

google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.